Quicksilver Biosciences Inc.

New York, NY

UEI
ZMEHBJ39DWK1
CAGE
83WM7
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1361 Amsterdam Ave #340, New York, NY 10027, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract subawards

Prime contractor Prime award Amount Awarded
The Trustees Of Columbia University In The City Of New York COLUMBIA - TEARWISE | OCULAB Quicksilver will be developing the fabrication process for integrating single-molecule field-effect transistors (smFET) devices… 140D042690006 $65,000

Grant awards

Award Agency Obligated Awarded
Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic… R44DE030841 National Institute of Dental and Craniofacial Research (NIH) $3,347,607
Sbir phase i: rapid covid-19 diagnostics with cmos-integrated single-molecule field-effect transistors 2031181 Division of Industrial Innovation $255,678
Sbir phase i: single-molecule field-effect transistor arrays for multiplexed genomic identification of infectious… 1843244 Division of Industrial Innovation $225,000

Similar vendors

Vendor Location Primary NAICS
Nexogen Inc. UEI YULBN2FLVDL3 San Diego, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Retham Technologies, Inc. UEI KDM9HGS7NFT9 Wauwatosa, WI 325413 In-Vitro Diagnostic Substance Manufacturing
Niti Inc. UEI NLHNVBKVZ5F7 Oklahoma City, OK 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

See more similar vendors on GovTribe

SBA capabilities narrative

From the vendor's SBA profile

Research and development of genomic diagnostic platform

Quick answers

Is Quicksilver Biosciences Inc. registered in SAM.gov?

Yes. Quicksilver Biosciences Inc.'s SAM.gov registration is active through March 16, 2027.

What is Quicksilver Biosciences Inc.'s most recent federal award?

Quicksilver Biosciences Inc.'s most recent federal grant award is Direct bioelectronic detection of sars-COV-2 from saliva using single-molecule field-effect transistor array nucleic… (R44DE030841), from National Institute of Dental and Craniofacial Research (NIH), on December 21, 2020.

On GovTribe

See Quicksilver Biosciences Inc.'s full federal record

  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login